tirzepatide march 19th FDA Grants a New Indication for Obesity Management Tirzepatide

MK-677 is prohibited under S2.2.4 as a growth hormone secretagogue mimetic

Support Your Weight Loss Journey with Semaglutide and Tirzepatide

I am substantially healthier & more energetic these days

Separately, the stimulant lisdexamfetamine (Vyvanse) is FDA-approved for binge-eating disorder, which sometimes overlaps with ADHD

Resources like SeekPeptides provide updated protocols, dosing charts , and community experiences that evolve as more real-world data becomes available

In fact, research suggests that pairing the two together may be more effective at reducing blood sugar levels and body weight than metformin alone (at least in people with type 2 diabetes)